The novel therapy of the medication represents a major advance in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide591403.widblog.com/96924857/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment